对比增强乳腺X线摄影(CEM)在乳腺癌术前分期中的评估:大规模单中心经验,更新至1005例
本研究回顾性分析2016年6月至2021年6月单中心991例女性、1005个恶性病灶的术前分期CEM检查,评估CEM对手术方式、额外活检或影像检查及额外病灶识别的影响。CEM使22.8%(226/991)患者的手术方案较常规影像改变,总体敏感度91.5%、特异度96.8%、AUC 0.941。结论重申CEM在大样本队列中对乳腺癌术前分期具有高诊断准确性。
要点
- CEM术前分期使22.8%(226/991)患者的手术方案较常规影像发生改变。
- CEM总体敏感度91.5%(204/223)、特异度96.8%(757/782)、AUC 0.941。
- CEM在低BPE水平患者中表现优于高BPE水平患者(ρ=0.028861)。
核心结论
- 本研究在大样本患者队列中重申了CEM对乳腺癌术前分期具有高诊断准确性。
研究设计与样本
- 单中心回顾性研究,纳入2016年6月至2021年6月术前分期CEM检查的991例女性、1005个恶性病灶,平均年龄61.3岁(范围35-93岁)。
关键影像表现/征象
- CEM识别出额外病灶是模型中唯一显著的预测因子。
- CEM在低BPE水平患者中的诊断表现优于高BPE水平患者(ρ=0.028861)。
诊断标准与关键数值
- CEM总体敏感度91.5%(204/223)、特异度96.8%(757/782)、阳性预测值89.1%(204/229)、阴性预测值97.5%(757/776)、准确率95.6%(961/1005)。
- ROC曲线AUC为0.941。
临床应用与阅片要点
- CEM可使36.7%(364/991)女性接受额外影像检查,18.5%(183/991)女性接受额外活检。
- CEM使22.8%(226/991)患者的手术方案较常规影像发生改变。
- CEM在低BPE水平患者中表现优于高BPE水平患者(ρ=0.028861)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of this study was to assess the diagnostic performance of CEM in the preoperative staging of breast cancer in a large cohort of patients.
MATERIALS AND METHODS: A retrospective review of preoperative staging CEM exams was conducted at our centre between June 2016 and June 2021. We evaluated cases where CEM influenced the type of surgery, necessitated additional biopsies or imaging, and identified additional lesions. The sensitivity, specificity, positive and negative predictive values (PPV and NPV), and accuracy of CEM for the entire sample and each subgroup setting were calculated. A receiver operating characteristic (ROC) curve and multivariate analysis were performed.
RESULTS: 991 women, mean age 61.3 years old [35-93], with 1005 malignant lesions were included. CEM led to additional imaging in 36.7% (364/991) women and to additional biopsies in 18.5% (183/991) women. CEM altered the initial surgical plan based on conventional imaging in 226 out of 991 patients (22.8%). CEM had a sensitivity in the whole population of 91.5% (204/223), specificity of 96.8% (757/782), PPV of 89.1% (204/229), NPV of 97.5% (757/776) and an accuracy of 95.6% (961/1005); the AUC of the ROC curve was 0.941. We found CEM better performed in patients with a low BPE level compared with a high BPE level (ρ = 0.028861). We see that the presence of additional lesions at CEM was the only significant predictor in the model.
CONCLUSION: This study reaffirms the high diagnostic accuracy of CEM for preoperative breast cancer staging in a large patient cohort.
引用
- Bicchierai G, Migliaro G, Pugliese F, et al. Evaluation of contrast-enhanced mammography (CEM) in the preoperative staging of breast cancer: large-scale single center experience, update to 1005 cases. Radiol Med. 2025. PMID: 40153207. doi:10.1007/s11547-025-02009-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。